Novavax working on formulating new vaccine to counter …

On Friday, November 26, biotechnology company Novavax stated that it has started working on the formulation of a new vaccine in view of the recent Omicron COVID variant detected in South Africa, reported CNN. The company has already begun developing a novel recombinant spike protein based on the known genetic sequence of B.1.1.529, and it will be available for testing and production in the …

https://www.republicworld.com/world-news/us-news/novavax-working-on-formulating-new-vaccine-to-counter-omicron-covid-variant-reports.html